Clinical Trial Update: Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating various doses and durations of a regimen including linezolid with bedaquiline and pretomanid for drug-resistant tuberculosis; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pre-xdr-tb
• Pulmonary Tuberculosis
• Tuberculosis
• Xdr-tb

Drugs mentioned

• Linezolid (Linezolid)
• Pretomanid (pretomanid)
• bedaquiline (bedaquiline)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 3 | Status: COMPLETED | Results posted: 2023-06-29